nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—Hyperaemia—Carmustine—malignant glioma	0.0251	0.0483	CcSEcCtD
Indinavir—Opportunistic infection—Temozolomide—malignant glioma	0.0182	0.035	CcSEcCtD
Indinavir—Lopinavir—CYP2B6—malignant glioma	0.0136	0.518	CrCbGaD
Indinavir—Skin hyperpigmentation—Carmustine—malignant glioma	0.0127	0.0245	CcSEcCtD
Indinavir—Nelfinavir—CYP2B6—malignant glioma	0.0127	0.482	CrCbGaD
Indinavir—Herpes zoster—Temozolomide—malignant glioma	0.00972	0.0187	CcSEcCtD
Indinavir—Cholestasis—Temozolomide—malignant glioma	0.00964	0.0186	CcSEcCtD
Indinavir—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00805	0.0155	CcSEcCtD
Indinavir—Herpes simplex—Temozolomide—malignant glioma	0.00794	0.0153	CcSEcCtD
Indinavir—Respiratory failure—Temozolomide—malignant glioma	0.00745	0.0144	CcSEcCtD
Indinavir—Musculoskeletal pain—Temozolomide—malignant glioma	0.00741	0.0143	CcSEcCtD
Indinavir—Influenza like illness—Temozolomide—malignant glioma	0.00711	0.0137	CcSEcCtD
Indinavir—Diabetes mellitus—Carmustine—malignant glioma	0.00632	0.0122	CcSEcCtD
Indinavir—Swelling—Carmustine—malignant glioma	0.00623	0.012	CcSEcCtD
Indinavir—Eye pain—Carmustine—malignant glioma	0.00609	0.0117	CcSEcCtD
Indinavir—Gastroenteritis—Temozolomide—malignant glioma	0.00599	0.0115	CcSEcCtD
Indinavir—Hepatic failure—Temozolomide—malignant glioma	0.00591	0.0114	CcSEcCtD
Indinavir—Eye pain—Temozolomide—malignant glioma	0.00588	0.0113	CcSEcCtD
Indinavir—Dry skin—Temozolomide—malignant glioma	0.00487	0.00938	CcSEcCtD
Indinavir—Muscular weakness—Carmustine—malignant glioma	0.00485	0.00934	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00478	0.00921	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00468	0.00902	CcSEcCtD
Indinavir—Muscular weakness—Temozolomide—malignant glioma	0.00468	0.00902	CcSEcCtD
Indinavir—Abdominal distension—Temozolomide—malignant glioma	0.00462	0.0089	CcSEcCtD
Indinavir—Dysuria—Temozolomide—malignant glioma	0.00429	0.00827	CcSEcCtD
Indinavir—Hyperglycaemia—Carmustine—malignant glioma	0.00429	0.00825	CcSEcCtD
Indinavir—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00427	0.00822	CcSEcCtD
Indinavir—Pneumonia—Carmustine—malignant glioma	0.00426	0.00821	CcSEcCtD
Indinavir—Pollakiuria—Temozolomide—malignant glioma	0.00424	0.00817	CcSEcCtD
Indinavir—Weight increased—Temozolomide—malignant glioma	0.00418	0.00805	CcSEcCtD
Indinavir—Renal failure—Carmustine—malignant glioma	0.00416	0.00802	CcSEcCtD
Indinavir—Neuropathy peripheral—Carmustine—malignant glioma	0.00415	0.008	CcSEcCtD
Indinavir—Hyperglycaemia—Temozolomide—malignant glioma	0.00414	0.00798	CcSEcCtD
Indinavir—Urinary tract infection—Carmustine—malignant glioma	0.00412	0.00793	CcSEcCtD
Indinavir—Pneumonia—Temozolomide—malignant glioma	0.00412	0.00793	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00406	0.00782	CcSEcCtD
Indinavir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00401	0.00773	CcSEcCtD
Indinavir—Urinary tract infection—Temozolomide—malignant glioma	0.00398	0.00766	CcSEcCtD
Indinavir—Hepatobiliary disease—Temozolomide—malignant glioma	0.00387	0.00746	CcSEcCtD
Indinavir—Sinusitis—Temozolomide—malignant glioma	0.00384	0.0074	CcSEcCtD
Indinavir—Haemoglobin—Carmustine—malignant glioma	0.00382	0.00736	CcSEcCtD
Indinavir—Haemorrhage—Carmustine—malignant glioma	0.0038	0.00732	CcSEcCtD
Indinavir—Hypoaesthesia—Carmustine—malignant glioma	0.00378	0.00729	CcSEcCtD
Indinavir—Connective tissue disorder—Carmustine—malignant glioma	0.00374	0.0072	CcSEcCtD
Indinavir—Haemoglobin—Temozolomide—malignant glioma	0.00369	0.00711	CcSEcCtD
Indinavir—Hepatitis—Temozolomide—malignant glioma	0.00367	0.00708	CcSEcCtD
Indinavir—Haemorrhage—Temozolomide—malignant glioma	0.00367	0.00708	CcSEcCtD
Indinavir—Hypoaesthesia—Temozolomide—malignant glioma	0.00366	0.00704	CcSEcCtD
Indinavir—Pharyngitis—Temozolomide—malignant glioma	0.00365	0.00702	CcSEcCtD
Indinavir—Urinary tract disorder—Temozolomide—malignant glioma	0.00363	0.00699	CcSEcCtD
Indinavir—Connective tissue disorder—Temozolomide—malignant glioma	0.00361	0.00695	CcSEcCtD
Indinavir—Urethral disorder—Temozolomide—malignant glioma	0.0036	0.00694	CcSEcCtD
Indinavir—Flushing—Carmustine—malignant glioma	0.00353	0.0068	CcSEcCtD
Indinavir—Erythema multiforme—Temozolomide—malignant glioma	0.00347	0.00669	CcSEcCtD
Indinavir—Flushing—Temozolomide—malignant glioma	0.00341	0.00657	CcSEcCtD
Indinavir—Alopecia—Carmustine—malignant glioma	0.00336	0.00647	CcSEcCtD
Indinavir—Immune system disorder—Temozolomide—malignant glioma	0.00332	0.00639	CcSEcCtD
Indinavir—Malnutrition—Carmustine—malignant glioma	0.00331	0.00638	CcSEcCtD
Indinavir—Chills—Temozolomide—malignant glioma	0.0033	0.00635	CcSEcCtD
Indinavir—Alopecia—Temozolomide—malignant glioma	0.00325	0.00625	CcSEcCtD
Indinavir—Back pain—Carmustine—malignant glioma	0.0032	0.00617	CcSEcCtD
Indinavir—Malnutrition—Temozolomide—malignant glioma	0.0032	0.00616	CcSEcCtD
Indinavir—Dysgeusia—Temozolomide—malignant glioma	0.00313	0.00603	CcSEcCtD
Indinavir—Vision blurred—Carmustine—malignant glioma	0.00312	0.00601	CcSEcCtD
Indinavir—Tremor—Carmustine—malignant glioma	0.0031	0.00597	CcSEcCtD
Indinavir—Back pain—Temozolomide—malignant glioma	0.00309	0.00596	CcSEcCtD
Indinavir—Anaemia—Carmustine—malignant glioma	0.00306	0.00589	CcSEcCtD
Indinavir—Agitation—Carmustine—malignant glioma	0.00304	0.00586	CcSEcCtD
Indinavir—Vision blurred—Temozolomide—malignant glioma	0.00301	0.00581	CcSEcCtD
Indinavir—Tremor—Temozolomide—malignant glioma	0.003	0.00577	CcSEcCtD
Indinavir—Ill-defined disorder—Temozolomide—malignant glioma	0.00297	0.00572	CcSEcCtD
Indinavir—Anaemia—Temozolomide—malignant glioma	0.00296	0.00569	CcSEcCtD
Indinavir—Agitation—Temozolomide—malignant glioma	0.00294	0.00566	CcSEcCtD
Indinavir—Angioedema—Temozolomide—malignant glioma	0.00292	0.00563	CcSEcCtD
Indinavir—Malaise—Temozolomide—malignant glioma	0.00288	0.00556	CcSEcCtD
Indinavir—Vertigo—Temozolomide—malignant glioma	0.00287	0.00554	CcSEcCtD
Indinavir—Palpitations—Temozolomide—malignant glioma	0.00283	0.00544	CcSEcCtD
Indinavir—Myalgia—Carmustine—malignant glioma	0.00282	0.00543	CcSEcCtD
Indinavir—Chest pain—Carmustine—malignant glioma	0.00282	0.00543	CcSEcCtD
Indinavir—Anxiety—Carmustine—malignant glioma	0.00281	0.00541	CcSEcCtD
Indinavir—Cough—Temozolomide—malignant glioma	0.00279	0.00538	CcSEcCtD
Indinavir—Myalgia—Temozolomide—malignant glioma	0.00272	0.00525	CcSEcCtD
Indinavir—Arthralgia—Temozolomide—malignant glioma	0.00272	0.00525	CcSEcCtD
Indinavir—Anxiety—Temozolomide—malignant glioma	0.00271	0.00523	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0027	0.00521	CcSEcCtD
Indinavir—Oedema—Carmustine—malignant glioma	0.0027	0.0052	CcSEcCtD
Indinavir—Discomfort—Temozolomide—malignant glioma	0.00269	0.00518	CcSEcCtD
Indinavir—Dry mouth—Temozolomide—malignant glioma	0.00266	0.00513	CcSEcCtD
Indinavir—Thrombocytopenia—Carmustine—malignant glioma	0.00265	0.00509	CcSEcCtD
Indinavir—Oedema—Temozolomide—malignant glioma	0.00261	0.00503	CcSEcCtD
Indinavir—Anaphylactic shock—Temozolomide—malignant glioma	0.00261	0.00503	CcSEcCtD
Indinavir—Anorexia—Carmustine—malignant glioma	0.00258	0.00496	CcSEcCtD
Indinavir—Nervous system disorder—Temozolomide—malignant glioma	0.00256	0.00493	CcSEcCtD
Indinavir—Thrombocytopenia—Temozolomide—malignant glioma	0.00256	0.00492	CcSEcCtD
Indinavir—Skin disorder—Temozolomide—malignant glioma	0.00254	0.00488	CcSEcCtD
Indinavir—Hyperhidrosis—Temozolomide—malignant glioma	0.00252	0.00486	CcSEcCtD
Indinavir—Anorexia—Temozolomide—malignant glioma	0.00249	0.00479	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00246	0.00474	CcSEcCtD
Indinavir—Insomnia—Carmustine—malignant glioma	0.00244	0.00471	CcSEcCtD
Indinavir—Paraesthesia—Carmustine—malignant glioma	0.00243	0.00467	CcSEcCtD
Indinavir—Dyspnoea—Carmustine—malignant glioma	0.00241	0.00464	CcSEcCtD
Indinavir—Somnolence—Carmustine—malignant glioma	0.0024	0.00463	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00238	0.00458	CcSEcCtD
Indinavir—Insomnia—Temozolomide—malignant glioma	0.00236	0.00455	CcSEcCtD
Indinavir—Decreased appetite—Carmustine—malignant glioma	0.00235	0.00452	CcSEcCtD
Indinavir—Paraesthesia—Temozolomide—malignant glioma	0.00234	0.00451	CcSEcCtD
Indinavir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00233	0.00449	CcSEcCtD
Indinavir—Dyspnoea—Temozolomide—malignant glioma	0.00233	0.00448	CcSEcCtD
Indinavir—Somnolence—Temozolomide—malignant glioma	0.00232	0.00447	CcSEcCtD
Indinavir—Constipation—Carmustine—malignant glioma	0.00231	0.00445	CcSEcCtD
Indinavir—Pain—Carmustine—malignant glioma	0.00231	0.00445	CcSEcCtD
Indinavir—Dyspepsia—Temozolomide—malignant glioma	0.0023	0.00443	CcSEcCtD
Indinavir—Decreased appetite—Temozolomide—malignant glioma	0.00227	0.00437	CcSEcCtD
Indinavir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00225	0.00434	CcSEcCtD
Indinavir—Fatigue—Temozolomide—malignant glioma	0.00225	0.00434	CcSEcCtD
Indinavir—Constipation—Temozolomide—malignant glioma	0.00223	0.0043	CcSEcCtD
Indinavir—Pain—Temozolomide—malignant glioma	0.00223	0.0043	CcSEcCtD
Indinavir—Feeling abnormal—Carmustine—malignant glioma	0.00223	0.00429	CcSEcCtD
Indinavir—Gastrointestinal pain—Carmustine—malignant glioma	0.00221	0.00425	CcSEcCtD
Indinavir—Feeling abnormal—Temozolomide—malignant glioma	0.00215	0.00414	CcSEcCtD
Indinavir—Body temperature increased—Carmustine—malignant glioma	0.00214	0.00411	CcSEcCtD
Indinavir—Abdominal pain—Carmustine—malignant glioma	0.00214	0.00411	CcSEcCtD
Indinavir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00213	0.00411	CcSEcCtD
Indinavir—Urticaria—Temozolomide—malignant glioma	0.00207	0.00399	CcSEcCtD
Indinavir—Body temperature increased—Temozolomide—malignant glioma	0.00206	0.00397	CcSEcCtD
Indinavir—Abdominal pain—Temozolomide—malignant glioma	0.00206	0.00397	CcSEcCtD
Indinavir—Hypersensitivity—Carmustine—malignant glioma	0.00199	0.00383	CcSEcCtD
Indinavir—Asthenia—Carmustine—malignant glioma	0.00194	0.00373	CcSEcCtD
Indinavir—Hypersensitivity—Temozolomide—malignant glioma	0.00192	0.0037	CcSEcCtD
Indinavir—Asthenia—Temozolomide—malignant glioma	0.00187	0.00361	CcSEcCtD
Indinavir—Diarrhoea—Carmustine—malignant glioma	0.00185	0.00356	CcSEcCtD
Indinavir—Pruritus—Temozolomide—malignant glioma	0.00185	0.00356	CcSEcCtD
Indinavir—Dizziness—Carmustine—malignant glioma	0.00179	0.00344	CcSEcCtD
Indinavir—Diarrhoea—Temozolomide—malignant glioma	0.00179	0.00344	CcSEcCtD
Indinavir—Dizziness—Temozolomide—malignant glioma	0.00173	0.00332	CcSEcCtD
Indinavir—Vomiting—Carmustine—malignant glioma	0.00172	0.00331	CcSEcCtD
Indinavir—Rash—Carmustine—malignant glioma	0.0017	0.00328	CcSEcCtD
Indinavir—Dermatitis—Carmustine—malignant glioma	0.0017	0.00328	CcSEcCtD
Indinavir—Headache—Carmustine—malignant glioma	0.00169	0.00326	CcSEcCtD
Indinavir—Vomiting—Temozolomide—malignant glioma	0.00166	0.0032	CcSEcCtD
Indinavir—Rash—Temozolomide—malignant glioma	0.00165	0.00317	CcSEcCtD
Indinavir—Dermatitis—Temozolomide—malignant glioma	0.00164	0.00317	CcSEcCtD
Indinavir—Headache—Temozolomide—malignant glioma	0.00164	0.00315	CcSEcCtD
Indinavir—Nausea—Carmustine—malignant glioma	0.0016	0.00309	CcSEcCtD
Indinavir—Nausea—Temozolomide—malignant glioma	0.00155	0.00299	CcSEcCtD
Indinavir—CYP3A7—Metabolism—BCHE—malignant glioma	0.00012	0.000264	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000119	0.000261	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000118	0.000261	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CAT—malignant glioma	0.000118	0.00026	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—IDH2—malignant glioma	0.000117	0.000257	CbGpPWpGaD
Indinavir—ABCC1—Disease—PDGFRA—malignant glioma	0.000115	0.000253	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000114	0.000251	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—IDH2—malignant glioma	0.000114	0.00025	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—NCOR1—malignant glioma	0.000112	0.000246	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—BCHE—malignant glioma	0.000112	0.000245	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000111	0.000244	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—SLC5A5—malignant glioma	0.00011	0.000242	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00011	0.000242	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.00011	0.000241	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTP1—malignant glioma	0.000109	0.000241	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—COX8A—malignant glioma	0.000109	0.00024	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—IDH2—malignant glioma	0.000107	0.000236	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000107	0.000236	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CAT—malignant glioma	0.000106	0.000234	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—IDH2—malignant glioma	0.000106	0.000234	CbGpPWpGaD
Indinavir—ABCC1—Disease—TERT—malignant glioma	0.000106	0.000233	CbGpPWpGaD
Indinavir—ABCC1—Disease—HLA-A—malignant glioma	0.000106	0.000233	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000105	0.000232	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000105	0.000231	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTP1—malignant glioma	0.000104	0.000229	CbGpPWpGaD
Indinavir—ABCC1—Disease—PDGFB—malignant glioma	0.000103	0.000227	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000103	0.000226	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGFR1—malignant glioma	0.000103	0.000226	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000101	0.000223	CbGpPWpGaD
Indinavir—ABCC1—Disease—HIF1A—malignant glioma	0.000101	0.000223	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CAT—malignant glioma	0.000101	0.000223	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000101	0.000222	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NCOR1—malignant glioma	0.0001	0.000221	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—IDH1—malignant glioma	0.0001	0.000221	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.0001	0.000221	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.0001	0.00022	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTT1—malignant glioma	9.95e-05	0.000219	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—IDH1—malignant glioma	9.79e-05	0.000215	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.78e-05	0.000215	CbGpPWpGaD
Indinavir—ABCC1—Disease—CAV1—malignant glioma	9.78e-05	0.000215	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.71e-05	0.000214	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SPHK1—malignant glioma	9.7e-05	0.000214	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NCOR1—malignant glioma	9.55e-05	0.00021	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTP1—malignant glioma	9.54e-05	0.00021	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2C18—malignant glioma	9.51e-05	0.000209	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SPHK1—malignant glioma	9.47e-05	0.000208	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS1—malignant glioma	9.32e-05	0.000205	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CAT—malignant glioma	9.28e-05	0.000204	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2C18—malignant glioma	9.28e-05	0.000204	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ASMT—malignant glioma	9.25e-05	0.000204	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—IDH1—malignant glioma	9.22e-05	0.000203	CbGpPWpGaD
Indinavir—ABCC1—Disease—BAD—malignant glioma	9.2e-05	0.000202	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—IDH1—malignant glioma	9.14e-05	0.000201	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOTCH1—malignant glioma	9.11e-05	0.0002	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CAV1—malignant glioma	9.1e-05	0.0002	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.97e-05	0.000197	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SPHK1—malignant glioma	8.93e-05	0.000196	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD80—malignant glioma	8.93e-05	0.000196	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.92e-05	0.000196	CbGpPWpGaD
Indinavir—ABCC1—Disease—APC—malignant glioma	8.91e-05	0.000196	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTP1—malignant glioma	8.88e-05	0.000195	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SPHK1—malignant glioma	8.85e-05	0.000195	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGF—malignant glioma	8.81e-05	0.000194	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NCOR1—malignant glioma	8.76e-05	0.000193	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTPN11—malignant glioma	8.75e-05	0.000193	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2C18—malignant glioma	8.74e-05	0.000192	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BCAN—malignant glioma	8.7e-05	0.000191	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.7e-05	0.000191	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.67e-05	0.000191	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—BCHE—malignant glioma	8.66e-05	0.000191	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CAT—malignant glioma	8.64e-05	0.00019	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.63e-05	0.00019	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—SLC5A5—malignant glioma	8.56e-05	0.000188	CbGpPWpGaD
Indinavir—ABCC1—Disease—BRAF—malignant glioma	8.37e-05	0.000184	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CG—malignant glioma	8.29e-05	0.000182	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CAV1—malignant glioma	8.19e-05	0.00018	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.17e-05	0.00018	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.17e-05	0.00018	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NCOR1—malignant glioma	8.16e-05	0.000179	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT2—malignant glioma	8.15e-05	0.000179	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARG—malignant glioma	8e-05	0.000176	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.88e-05	0.000173	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CD—malignant glioma	7.83e-05	0.000172	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.83e-05	0.000172	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CAV1—malignant glioma	7.78e-05	0.000171	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTT1—malignant glioma	7.69e-05	0.000169	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTT1—malignant glioma	7.51e-05	0.000165	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGF2—malignant glioma	7.5e-05	0.000165	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—malignant glioma	7.46e-05	0.000164	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.45e-05	0.000164	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.44e-05	0.000164	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CD—malignant glioma	7.29e-05	0.00016	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.28e-05	0.00016	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS1—malignant glioma	7.21e-05	0.000159	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARG—malignant glioma	7.2e-05	0.000158	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.19e-05	0.000158	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.18e-05	0.000158	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CAV1—malignant glioma	7.14e-05	0.000157	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—malignant glioma	7.09e-05	0.000156	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTT1—malignant glioma	7.07e-05	0.000156	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS1—malignant glioma	7.03e-05	0.000155	CbGpPWpGaD
Indinavir—ABCC1—Disease—MDM2—malignant glioma	7.02e-05	0.000154	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—IDH2—malignant glioma	7.01e-05	0.000154	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTT1—malignant glioma	7.01e-05	0.000154	CbGpPWpGaD
Indinavir—ABCC1—Disease—RAF1—malignant glioma	6.99e-05	0.000154	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—malignant glioma	6.92e-05	0.000152	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—malignant glioma	6.89e-05	0.000152	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARG—malignant glioma	6.84e-05	0.000151	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CB—malignant glioma	6.83e-05	0.00015	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—malignant glioma	6.76e-05	0.000149	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAT—malignant glioma	6.71e-05	0.000148	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—BCHE—malignant glioma	6.7e-05	0.000147	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CAV1—malignant glioma	6.65e-05	0.000146	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS1—malignant glioma	6.63e-05	0.000146	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.62e-05	0.000146	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.59e-05	0.000145	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS1—malignant glioma	6.57e-05	0.000145	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CD—malignant glioma	6.56e-05	0.000144	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.55e-05	0.000144	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—BCHE—malignant glioma	6.54e-05	0.000144	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—malignant glioma	6.51e-05	0.000143	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC5A5—malignant glioma	6.46e-05	0.000142	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CB—malignant glioma	6.35e-05	0.00014	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NCOR1—malignant glioma	6.34e-05	0.000139	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—malignant glioma	6.3e-05	0.000139	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—malignant glioma	6.28e-05	0.000138	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.26e-05	0.000138	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CD—malignant glioma	6.23e-05	0.000137	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.2e-05	0.000136	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—BCHE—malignant glioma	6.16e-05	0.000136	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—BCHE—malignant glioma	6.11e-05	0.000134	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.09e-05	0.000134	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—malignant glioma	6.06e-05	0.000133	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.03e-05	0.000133	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—IDH1—malignant glioma	6.03e-05	0.000133	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.95e-05	0.000131	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—malignant glioma	5.9e-05	0.00013	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—malignant glioma	5.85e-05	0.000129	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SPHK1—malignant glioma	5.84e-05	0.000128	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—malignant glioma	5.72e-05	0.000126	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—malignant glioma	5.72e-05	0.000126	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.72e-05	0.000126	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.71e-05	0.000126	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—malignant glioma	5.67e-05	0.000125	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.65e-05	0.000124	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—malignant glioma	5.49e-05	0.000121	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—malignant glioma	5.43e-05	0.00012	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.41e-05	0.000119	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—malignant glioma	5.38e-05	0.000118	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—malignant glioma	5.33e-05	0.000117	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—malignant glioma	5.32e-05	0.000117	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—malignant glioma	5.28e-05	0.000116	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—malignant glioma	5.2e-05	0.000114	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAT—malignant glioma	5.19e-05	0.000114	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAV1—malignant glioma	5.16e-05	0.000114	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAT—malignant glioma	5.06e-05	0.000111	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.99e-05	0.00011	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—malignant glioma	4.94e-05	0.000109	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—malignant glioma	4.94e-05	0.000109	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.93e-05	0.000108	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—malignant glioma	4.9e-05	0.000108	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—malignant glioma	4.9e-05	0.000108	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NCOR1—malignant glioma	4.9e-05	0.000108	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—malignant glioma	4.86e-05	0.000107	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—malignant glioma	4.8e-05	0.000106	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NCOR1—malignant glioma	4.78e-05	0.000105	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAT—malignant glioma	4.77e-05	0.000105	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAT—malignant glioma	4.73e-05	0.000104	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.7e-05	0.000104	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—malignant glioma	4.7e-05	0.000103	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—malignant glioma	4.64e-05	0.000102	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—malignant glioma	4.62e-05	0.000102	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—malignant glioma	4.6e-05	0.000101	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—malignant glioma	4.54e-05	9.99e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—malignant glioma	4.53e-05	9.97e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NCOR1—malignant glioma	4.5e-05	9.91e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NCOR1—malignant glioma	4.47e-05	9.83e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS1—malignant glioma	4.33e-05	9.53e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—malignant glioma	4.31e-05	9.48e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—malignant glioma	4.16e-05	9.16e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.14e-05	9.1e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BCHE—malignant glioma	4.03e-05	8.86e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—malignant glioma	4.01e-05	8.82e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAV1—malignant glioma	3.99e-05	8.79e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.98e-05	8.76e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAV1—malignant glioma	3.9e-05	8.58e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—malignant glioma	3.87e-05	8.52e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.81e-05	8.39e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAV1—malignant glioma	3.67e-05	8.08e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAV1—malignant glioma	3.64e-05	8.01e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.64e-05	8e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.6e-05	7.93e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—malignant glioma	3.57e-05	7.86e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—malignant glioma	3.55e-05	7.81e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—malignant glioma	3.51e-05	7.72e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—malignant glioma	3.49e-05	7.67e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.48e-05	7.65e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—malignant glioma	3.43e-05	7.54e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—malignant glioma	3.4e-05	7.48e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.35e-05	7.36e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.32e-05	7.3e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—malignant glioma	3.31e-05	7.29e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—malignant glioma	3.23e-05	7.1e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—malignant glioma	3.21e-05	7.05e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—malignant glioma	3.2e-05	7.04e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.2e-05	7.04e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—malignant glioma	3.16e-05	6.96e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—malignant glioma	3.12e-05	6.87e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAT—malignant glioma	3.12e-05	6.86e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—malignant glioma	3.11e-05	6.85e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.04e-05	6.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOR1—malignant glioma	2.95e-05	6.48e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.94e-05	6.47e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.92e-05	6.41e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—malignant glioma	2.85e-05	6.27e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.83e-05	6.23e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.79e-05	6.13e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—malignant glioma	2.76e-05	6.08e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—malignant glioma	2.72e-05	5.99e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—malignant glioma	2.71e-05	5.95e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—malignant glioma	2.7e-05	5.93e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.56e-05	5.64e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.54e-05	5.59e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—malignant glioma	2.54e-05	5.59e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—malignant glioma	2.52e-05	5.54e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—malignant glioma	2.48e-05	5.46e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—malignant glioma	2.41e-05	5.3e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAV1—malignant glioma	2.4e-05	5.28e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—malignant glioma	2.35e-05	5.17e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—malignant glioma	2.31e-05	5.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—malignant glioma	2.21e-05	4.87e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.2e-05	4.84e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—malignant glioma	2.2e-05	4.83e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.19e-05	4.81e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—malignant glioma	2.11e-05	4.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.92e-05	4.23e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—malignant glioma	1.8e-05	3.95e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.7e-05	3.74e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.68e-05	3.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—malignant glioma	1.66e-05	3.65e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—malignant glioma	1.66e-05	3.65e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.56e-05	3.44e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.55e-05	3.41e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—malignant glioma	1.45e-05	3.19e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—malignant glioma	1.39e-05	3.05e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—malignant glioma	1.35e-05	2.98e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—malignant glioma	1.28e-05	2.81e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—malignant glioma	1.27e-05	2.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.02e-05	2.25e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—malignant glioma	8.35e-06	1.84e-05	CbGpPWpGaD
